牛牛AI助手已提取核心信息绿叶制药集团2025年上半年收入同比增长3.5%至人民币31.81亿元，毛利率维持在67.8%。肿瘤治疗领域收入大幅增长13.5%至人民币12.95亿元，中枢神经系统治疗领域收入增长5.4%至人民币8.67亿元。然而，股东应占溢利同比下降19.3%至人民币3.13亿元。集团研发实力持续增强，拥有611名研发人员，包括59名博士及299名硕士。截至2025年6月30日，集团...
Source Link牛牛AI助手已提取核心信息绿叶制药集团2025年上半年收入同比增长3.5%至人民币31.81亿元，毛利率维持在67.8%。肿瘤治疗领域收入大幅增长13.5%至人民币12.95亿元，中枢神经系统治疗领域收入增长5.4%至人民币8.67亿元。然而，股东应占溢利同比下降19.3%至人民币3.13亿元。集团研发实力持续增强，拥有611名研发人员，包括59名博士及299名硕士。截至2025年6月30日，集团...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.